(Q36192802)

12 August 2017

1 reference

title

Pharmacogenomics and functional gastrointestinal disorders (English)

1 reference

12 August 2017

1 reference

1

Michael Camilleri

1 reference

12 August 2017

publication date

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

491-501

1 reference

AGA technical review on irritable bowel syndrome

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Management of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Familial aggregation of irritable bowel syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Definition and investigation of dyspepsia. Consensus of an international ad hoc working party

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Serotonergic mediation of postprandial colonic tonic and phasic responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Genes and the response to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Serotonin transporter gene polymorphism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Action of serotonin on the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Toward a molecular architecture of personality.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Biogenic amine transporters: regulation in flux

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.6.5.491

21 January 2018

Identifiers

DOI

10.2217/14622416.6.5.491

1 reference

12 August 2017

1 reference